Connect with us

HealthTech

Novartis to Acquire Biotech Startup Avidity Biosciences in $12 Billion Deal

Published

on

[ad_1]

Acquire News
Biotech
Health Care

Swiss pharmaceutical giant Novartis AG announced it has entered into a definitive agreement to acquire San Diego-based biotech company Avidity Biosciences for approximately…

[ad_2]

Source link

Continue Reading